Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2023Mar2022Mar2021
   EBIT Growth(%) -67.21-38.59-

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is -67.21 based on Mar2023 Consolidated results.
Year EBIT Growth
Mar2023-67.21
Mar2022-38.59
Mar2021-

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2023 -67.21
Negative
Mar2022 -38.59
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,836.9 Cr 2% 5.4% 107.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹351,467.0 Cr -4.9% -2.6% 54% Stock Analytics
CIPLA ₹119,470.0 Cr -0.1% 5% 57.6% Stock Analytics
DIVIS LABORATORIES ₹116,563.0 Cr 8.1% 9.1% 25.6% Stock Analytics
ZYDUS LIFESCIENCES ₹105,690.0 Cr -2.4% 10.8% 110% Stock Analytics
DR REDDYS LABORATORIES ₹99,351.1 Cr 1.4% -4.8% 30.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2%

5.4%

107.1%

SENSEX

1.7%

1.1%

21.3%


You may also like the below Video Courses